Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Vet Med Assoc ; 248(4): 422-9, 2016 Feb 15.
Article in English | MEDLINE | ID: mdl-26829275

ABSTRACT

OBJECTIVE: To investigate whether intraoperative administration of a lidocaine infusion to dogs with septic peritonitis was associated with short-term (48 hours) survival after surgery. DESIGN: Retrospective case series. ANIMALS: 75 dogs with septic peritonitis. PROCEDURES: Medical records of dogs with septic peritonitis that underwent laparotomy between January 2007 and December 2011 at the Royal Veterinary College were reviewed. Select variables during the preoperative, intraoperative, and postoperative periods and short-term survival after surgery were compared between dogs that received an opioid only (group O; n = 33) and dogs that received lidocaine (50 µg/kg/min [22.7 µg/kg/min], IV; group L; 42) in addition to an opioid during surgery. RESULTS: The proportion of dogs that survived for 48 hours after surgery was significantly greater for group L (35/42) than for group O (20/33). Intraoperative infusion of lidocaine increased the odds of short-term survival (OR, 8.77; 95% CI, 1.94 to 39.57). No significant differences were observed between the 2 treatment groups for variables assessed during the preoperative and postoperative periods. During the intraoperative period, more dogs in group L received an IV bolus of a synthetic colloid than did dogs in group O, but the number of IV boluses administered was not associated with short-term survival. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that IV infusion of lidocaine might improve the short-term survival of dogs with septic peritonitis. Prospective clinical trials are necessary to determine the efficacy of lidocaine as a supportive treatment for dogs with septic peritonitis.


Subject(s)
Anesthetics, Local/administration & dosage , Dog Diseases/drug therapy , Lidocaine/administration & dosage , Peritonitis/veterinary , Analgesics, Opioid/administration & dosage , Animals , Dog Diseases/mortality , Dog Diseases/surgery , Dogs , Female , Infusions, Intravenous/veterinary , Intraoperative Care/veterinary , Male , Peritonitis/drug therapy , Peritonitis/mortality , Peritonitis/surgery , Retrospective Studies , Survival Analysis
3.
Vet Anaesth Analg ; 41(3): 259-68, 2014 May.
Article in English | MEDLINE | ID: mdl-24330233

ABSTRACT

OBJECTIVE: To evaluate mortality in a canine population undergoing thoracic surgery and identify factors which may be associated with outcome. STUDY DESIGN: Retrospective cohort study. ANIMALS: 286 dogs anaesthetized for thoracic surgery at the Royal Veterinary College between June 2002 - June 2011. METHODS: Variables examined included: signalment; ASA status; nature of disease; presence of co-morbidities; pre-anaesthetic oxygen requirement; surgical approach; anaesthesia management [anaesthetic agents; requirement for thoracocentesis; central venous pressure measurement; duration of surgery and anaesthesia; use of colloids, blood products, inotropes or neuromuscular blocking agents (NMBA)]. Outcome was defined as either non-survival to 24 hours after surgery or (having survived to 24 hours) to discharge. Univariate and multivariable logistic regressions were performed to identify risk factors associated with non-survival. RESULTS: Overall non-survival (excluding those euthanased) to discharge was 5.9%. Non-survival was 2.2% at 24 hours and 3.6% at time of discharge. Non-survival to 24 hours was associated with pre-anaesthetic oxygen requirement (odds ratio (OR) 12.2 [95% CI 1.8-84.5]) and NMBA use (OR 9.6 [95% CI 1.6-57.9]). Non-survival to discharge was associated with surgical duration, with surgeries >180 minutes having OR 16.9 [95% CI 2.0-144.0] compared to surgeries ≤90 minutes and blood product use (OR 4.6 [95% CI 1.3-14.6]). No association was found between ASA category and non-survival at 24 hours (OR 1.4 [95% CI 0.2-11.7]) or discharge (OR 4.4 [95% CI 0.6-34.3]). Significant associations were found between NMBA use and ASA category (p = 0.046), surgical duration (p = 0.002), use of colloids (p = 0.011), blood products (p = 0.001) and inotropes and/or vasopressors (p < 0.001). CONCLUSIONS AND CLINICAL RELEVANCE: Variables significantly associated with non-survival from canine thoracic surgery at 24 hours include NMBA use and pre-anaesthetic oxygen requirement. Blood product use and increasing surgical duration were associated with non-survival to hospital discharge. The associations may relate to the need for such products in the most complicated cases.


Subject(s)
Dog Diseases/surgery , Thoracic Surgical Procedures/veterinary , Algorithms , Animals , Cohort Studies , Dogs , Odds Ratio , Retrospective Studies , Risk Factors , Thoracic Surgical Procedures/mortality
4.
Vet Anaesth Analg ; 40(2): 212-9, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23016595

ABSTRACT

OBJECTIVE: To compare the success by inexperienced anaesthetists of using a modified infraorbital approach to the maxillary nerve with the traditional percutaneous approach. STUDY DESIGN: Prospective, randomized, blinded controlled study. ANIMALS: Heads from 37 euthanized Beagle and Beagle cross dogs. METHODS: Four anaesthetists were recruited to perform two different approaches to block the maxillary nerve of the cadavers. The infraorbital (I) approach advanced an intravenous catheter along the infraorbital canal. Earlier measurements from scans of similar heads were used to assess suitable catheter size. The percutaneous (P) approach introduced a needle percutaneously just below the ventral border of the zygomatic arch. The side of the head where the technique was to be performed was randomized. A total volume of 0.5 mL methylene blue was injected in each approach. After completion of injections, head dissections were performed by an investigator unaware of the approach used and staining of the maxillary and pterygopalatine nerves was evaluated. Chi squared analysis examined the relationship between the methods (p < 0.05). Complications related to the techniques, such as intravascular/intraneural injection and location of the dye, were evaluated macroscopically. RESULTS: Maxillary nerve staining >6 mm was found in 64.9% (I) versus 21.6% (P) attempts; staining <6 mm was found in 27% (I) versus 21.6% (P); and no nerve staining 8.1% (I) versus 56.8% (M). Pterygopalatine nerve staining was found in 70% (I) versus 21% (P). The infraorbital approach demonstrated significantly higher maxillary and pterygopalatine nerve staining compared to the percutaneous approach (p = 0.001 for both nerves). No evidence of intravascular/intraneural injections was found. CONCLUSION AND CLINICAL RELEVANCE: The infraorbital approach was more successful than the percutaneous approach when performed by inexperienced anaesthetists. No macroscopic complications were observed.


Subject(s)
Dogs/anatomy & histology , Maxilla/innervation , Nerve Block/veterinary , Animals , Cadaver , Injections/veterinary , Nerve Block/methods , Staining and Labeling
SELECTION OF CITATIONS
SEARCH DETAIL
...